PROTHROMBIN G20210A (FACTOR II) MUTATION DETECTION, EDTA BLOOD

image not found

NABL Cap Accredited    
The Prothrombin G20210A (Factor II) Mutation Detection test identifies a specific genetic variant linked to an increased risk of abnormal blood clotting. This mutation can predispose individuals to deep vein thrombosis or other thrombotic events. Metropolis Healthcare performs this test using advanced molecular techniques to ensure precise detection of the mutation. It is recommended for individuals with unexplained clotting issues or a family history of thrombophilia.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 5,830.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: P0109

Frequently Asked Questions (FAQ's):

What does the Prothrombin G20210A Mutation test include at Metropolis Healthcare?
It analyzes the Factor II gene to check for the G20210A mutation associated with increased clotting risk.

How does Metropolis Healthcare perform this mutation detection test?
Metropolis Healthcare uses advanced PCR-based genetic testing to accurately identify the presence of the mutation.

Who should consider taking this test?
Individuals with recurrent clotting events, early-onset thrombosis, or a family history of thrombophilia should undergo this test at Metropolis Healthcare.

Do I need any preparation before giving the sample at Metropolis Healthcare?
No fasting or special preparation is required; only an EDTA blood sample is needed.

Why is this genetic test important?
It helps determine inherited clotting risk and guides preventive or therapeutic decisions for managing thrombophilia.

How soon can I receive my results from Metropolis Healthcare?
Metropolis Healthcare typically provides timely reports to support clinical evaluation and risk assessment.

Can this test help in family screening?
Yes, Metropolis Healthcare often recommends it for relatives of individuals diagnosed with the mutation.

Is this test useful for planning long-term treatment?
Yes, results help clinicians tailor anticoagulation strategies and lifestyle recommendations for patients with thrombotic risk.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab